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ABSTRACT 
The present study explored the utility of erythrocyte aldehyde dehydrogenase (ALDH) as a peripheral 
marker in alcoholism. The ALDH levels in aocoholics, their first degree nonalcholic relative and controls were 
compared. ALDH was found to be siginifkatly lower in alcoholics (3.38±1.70 mU p<0.001) and their first 
degree relatives (4.04±1.55 mU p<0.05) compared to controls (5.06±1 55mU). Low ALDH levels among 
alcoholics persisted despite abstinence. The levels dod not correlate with indices of hepatic dysfunction or 
with severity of alcoholism. These findings indicate that low erythrocyte ALDH may be considered as a 
biochemical trait marker associated with alcoholics, and the alcohol abuse would further decrease enzyme 
activitiy. To evaluate this proposition, logitudinal studies involving high risk progeny of alcohol dependents 
is being planned. 
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INTRODUCTION 
The familial nature of alcoholism and the asso-
ciated markers of the disease have been the subject of 
study by several groups (Ballenger et al 1979, Monteiro 
et al. 1988, Begleiter and Porjesz 1988). However, 
most of the laboratory based diagnostic parametrs are 
unsatisfactory because of nonspecificity. Hence, there 
is a need for an ideal biochemical marker of alcoholism. 
While the ideal biochemical marker of alcoholism would 
serve as a "state" marker confirming diagnosis and to 
assess the state of the disease before initiating thera-
peutic measures, the "trait" marker would be of im-
mense use in identifying the population at risk and to 
take peventive measures. The search is still on, for a 
reliable marker which could help physicians in their 
ability to diagnose alcoholism, monitor abstinence, iden-
tify high risk individuals and plan intervention strate-
gies. 
In recent times, one such marker that has 
aroused much interst is aldehyde dehydrogenase 
(ALDH). the en/yme which metabolises acetaldehyde, 
the intermediary metabolite of ethanol. Hepatic ALDH 
is present in both cytosolic and mitochondrial com-
partments, and (lie is present in both cytosolic and 
mitochondrial compartments, and the eythrocyte ALDH 
represents the cytosolic counterpart in liver. 
Selective reduction of cytosolic ALDH (hepat-
ic and erythrocyte) have been demonstrated in chronic 
alcoholics (Thomas et al., 1982; Agarwal et al 1983. 
Jenkins et al., 1984; Lin et al., 1984; Harada et al., 
1985; Mahtewson and Record, 1986; Towell et al., 
1986). While the latter researchers found a gradual 
return of the initially low cytosolic ALDH levels to 
normal following periods of abstinence ranging from 2 
to 8 weeks, suggesting that ALDH could serve as a 
marker of state, Thomas et al (1982) found persistent-
ly low ALDH levels even afer prolonged absinence. 
Their finding raises the possiblity that low cytosolic 
ALDH activity may represent a primary abnormality 
predisposing to alcoholism. Thus, it is unclear whether 
ALDH is a marker of state or trait. One way to 
resolve this controversy is to study cytosolic activity 
in relatives of alcoholics who do not drink alcohol 
excessively (Mathewson and Record, 1986). 
The present study was addressed towards 
answering this question by determining whether eryth 
rocyte (cytosolic) ALDH levels in alcoholics and their 
first degree relatives differed from nonalcoholic con-
trols: whether abstinence caused reversibility of eryth-
rocyte ALDH, and whedier erythrocyte ALDH levels 
correlated with the commonly employed indices of 
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hepatic dysfunction or quantity of alcohol consump-
tion. 
MATERIALS AND METHODS 
Sample Characteristics: 
The study group comprised of 57 male inpa-
tient alcoholics (mean age 38.91, SD = 8.3) satisfying 
DSM-111 criteia for alcohol dependence (Diagnostic 
and statistical Manual, APA, 1980) screened for the 
absence of exclusion criteria (viz., anaemia, severe 
malnutrition, concurrent dependence on other drugs, 
consumption in the prior 3 months of drugs known 
to alter ALDH activity (viz., Disulfiram, sulfonylureas, 
cephalosporins and nitrate antianginals). Details of 
alcohol consumption, alcohol related problems and 
family history were obtained by the use of a 
semistructured questionnaire. 
The first blood sample in the alcoholic group 
was drawn from the antecubital vein after overnight 
fasting within 24 to 72 hours after the last drink, 
before any treatment was instituted. Following this, 
the patients were detoxified with chlordiazepoxide 
(40-170) mg/day) or diazepam (10^0 mg/day). They 
were also given thiamine and other B complex 
suplements. Detoxification was usually completed 
within 2 weeks. Following 4 weeks of supervised 
abstinence (i.e. 2 weeks after stopping benzodiaepines) 
39 patients were reassessed for erythrocyte ALDH 
levels and liver functions tests. A third sample was 
analysed in 12 patients started on disulfiram in order 
to determine the effects of disulfiram on ALDH 
activity. In vitro effects, if any of drugs used in 
detoxification i.e., benzodiazepines and thiamine, on 
ALDH were also studied. 
The first degree relatives consisted of 26 
healthy males (mean age 28.92 years SD = 9.45). of 
this sample, 19 had never consumed alcohol, and 7 
Urnk only on social occasions.but had not consumed 
alcohol in the prior 2 weeks. 16 were brothers of 
patients. 9 were sons and 1 a father. 
The controls comprised 40 halthy male volun-
teers with no family history of alcohol depepndence 
(mean age 28.92 years SD=4.3), of whom 33 did not 
consume alcohol, and 7 drnk on social occasions. The 
^ame set of exclusion criteria as that for alcohol group 
applied to the controls and relatives. 
A heparinised blood sample was drawn from 
the antecubital vein after overnight fasting. Cells were 
separated by centrifugation ( 3000 rpm/15 mins) and 
the plasma was utilised for tests of liver function, in 
a Hitachi 705 autoanalyser (Boehringer Knoll). RBC's 
were lysed, rendered haemoglobin free by CM-Sephadex 
c-50 column elution and ALDH activity of the Hb-
free lysate was estimated spectro photometrically at 
340 run, using propionaldehyde as subtrate, at ph 7.4. 
by employing the method of Guru and Shetty (1990). 
ALDH activity was expressed as 'n' moles of NADH 
formed/min/mg protein. Protein estimation of the Hb 
free lysate was carried out by the dye binding method 
(Sedmak et al„ 1977). 
Data was sttistically analysed using student's 
't* test, paired 'f test analysis of variance, median test 
and chi-square test. Correlation between various indi-
ces of hepatic dysfunction were examined using 
ePearson's correlation coefficient. 
RESILTS 
Mean duration of alohol consumption in the 
study group was 14.57 years (SD = 7.86) and quan-
tity frequency index was 170.64g (SD = 128.3), 26 
patients had a family history of alcohoism. 
Erythrocyte ALDH was significantly lower in 
the alcoholic patients (3.381 ± 1.70 mU, p< 0.001) 
and in thier first degree relatives (4.035±1.55 mil, 
p<0.05) as compared with the control group (5.056± 
1.57 mU), 
Following 4 weeks of abstinence there was no 
significant change in erythrocyte ALDH values. 
Disulfiram completely inhibited ALDH activity 
TABLE 1 
Changes in erythrocyte ALDH values after 4 weeks of abstinence 
and after treatmen with disulfiram. 
N Erythrocyte ALDH activity (mU) 
Alcoholics 39 3.20 ± 1.70 
(Sample I) 
Alcoholics 39 3.30 ± 1.78 t=0.34. 
(Sample II) df=38 n.s 
Alcoholics 12 (no activity) 
(Sample III) 
(on disulfiram) 
values are mean + sd. 
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In vitro studies of the effect of drugs common-
ly used in detoxification indicated that benzodiazepines 
activated erythrocyte ALDH activity, but thiamine did 
not alter ALDH activity. 
Serum bilirubin, total cholesteol, plasma 
triglycerides and plasma magnesium did not differ 
significantly across the 3 groups. Mean Aspartate 
Aminotransferase (AST) values were significantly high-
er in the patient group (Table 2) 
TABLE 2 
Comparison of plasma enzymes of liver function 
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AST  ALT  GGT  ALDH 
Aunuxs 
FIRST 
DEGREE comas 
RELATIVES 
cm* p 
AST 96 91+121.9 23.08+86 19.54+S.83 48.64 >0.0001 
ALT 64.42+95.80 20.95+11.0 18.59+17.19 21.98 <0.05 
GGT 102.26+99.20 34.04+14.3 37.03+18.7718.59 <0.001. 
Values are mean + sd. 
* extension of Median test 
TABLE-3 
Liver function tests at intake (alcohol goup) and 
following 4 weeks of abstinence. 
ast 
ALT 
HP 
GGT 
n 
42 
34 
44 
36 
ALCOHOLCS 
SAMPLE 
100.6+124.90 
5479+6930 
11707+5050 
10183+100.70 
ALCOHOLCS 
SAMPLE2 
259+832 
2556t1520 
92.68±32.80 
58.19+59.48 
T 
48.64 
2.60 
24.10 
18.6 
P 
<fll)01 
<0.C6 
<0fD1 
-d0£01 
paired 't' test was used for comparison and 
decline signifiantly after abstinence (Table 3) Similar 
trends were noted with Alanine Aminotransferase (ALT) 
and Gmma Glutamy Transpeptidase (GGT). The 
improvements in the parametes of liver function (viz 
AST, ALT.GGT) were not associated with any 
concommitant iprovement in erythrocyte ALDH activ-
ity ( Fig-I) 
Relationship between Erythrcyte ALDH 
(Meant±SD) and Plasma LFT enzymes (Mena + SEM 
of Alcoholics (1st and Ilnd sampes). Aspartate Amino 
Transferase (AST), Alaniinine Amino Transferase 
(ALT), Gamma Glutamyl Transpeptidase (GGT), Al= 
AlcoholicFirst Sample, A2 = Alcoholic Second Sam-
ple. 
DISCUSSION 
Erthrocytes offer a suitable easily accessible 
peripheral source for monitoring cytosolic ALDH actiity 
in alcoholics. The methodlogical aspects of ALDH 
assay has been discussed earlier (Guru et al., 1990). 
This study examined inpatient alcoholics to 
ensure supervised abstinence. Patients who had recent-
ly been on drugs known to inhibit ALDH (Asad and 
Clarice 1976, Towell et al., 1985, Kitson 1986, Agarwa! 
et al, 1987) were excluded from the study. The second 
sample following abstinence was collected after 2 
weeks of cessation of detoxification with 
benzodiazepines, since in vitro experiments had shown 
increased ALDH activity with benzodiazepines 
(Murthy et al., 1991). 
This study found significantly low levels of 
cytosolic ALDH in chronic alcoholis. which persisted 
following abstinence, in concurrene with one earlier 
work (Thomas et al 1982). 
While the initial abnormal liver function tests 
showed a definite improvement after 4 weeks of 
abstinence, with recovery of hepatic function, in agree-
ment with earlier reports (Sherlock 1982). erythrocyte 
ALDH levels remained low. This suggests that low 
40 MURTHY UT AL 
ALDH activity is not an epiphenomenon of nonspe-
cific hepatic damage, as suggested by Mathewson and 
Record (1986), nor is a direct conseuence of alcohol 
consumption as earlier reported (Jenkins et al., 1984). 
This point is further substantiated by a lack of 
correlation between ALDH, indices of hepatic dys-
function and quantity frequency index. 
These observations were further corroborated 
by the finding of significantly lower ALDH values in 
first degree relatives of alcoholics as compared with 
controls. 
In conclusion, this study found significantly 
lower erythrocyte ALDH in alcoholics and their first 
degree relatives. The low levels of the enzyme per-
sisted despite abstinence. ALDH values did not cor-
relate with indices of hepatic dysfunction or severity 
of alcoholism. These findings suggest tht the observed 
low erythrocyte ALDH in alcoholics and their first 
degree relatives ould be a trait marker for alcoholism. 
Could erythrocyte ALDH help to identify a 
high risk, genetically vulnerable group? would the 
individuals with low ALDH levels be more prone to 
becoming alcohol dependent? These issues could be 
addressed by longitudinal studies. Findings from such 
a study woul probably help in counselling such 
individuals, in whom social drinking may not be a 
feasible alternative to complete abstinence. 
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